We previously showed high prevalence of chronic obstructive pulmonary disease (COPD) in an all-smoking cohort of HIV-individuals. Whether COPD prevalence is higher in HIV-individuals than in the general population remains to be determined. The objective of this study was to compare the prevalence of airflow obstruction (AO) in HIV-individuals and in age and gender matched individuals from the general population, and to determine whether HIV-status was an independent factor of AO.
HIV-infected individuals were included in the ANRS EP48 HIV-CHEST study (NCT01207986), a multicentre, French, lung cancer screening study with chest CT. Each HIV-individual was randomly matched by age and gender with two individuals from a general population cohort CONSTANCES. All individuals were smokers ≥ 20 pack-years, possibly stopped within the previous 3 years, and aged ≥ 40 years. HIV-individuals also had a CD4 T-lymphocyte nadir count < 350/μL, and a last CD4 T-lymphocyte count > 100/μL. Both populations underwent spirometry without administration of a bronchodilator. The primary endpoint defining AO was the forced expiratory volume in 1 second (FEV1)/ forced vital capacity (FVC) ratio < 0.70 and a FEV1 measure <80 % of the theoretical value. A logistic regression model evaluated the association of AO with age, gender, HIV status, Body Mass Index, smoking (pack-years), and former smoking.
351 HIV-infected individuals were matched to 702 subjects (table); 68 (19%) of HIV-infected versus 60 (9%) of HIV-negative individuals had AO. In multivariate analysis, factors associated with AO were HIV (OR: 2.03, 95% CI (1.33-3.10)), age (per 10 years increase) (OR 1.68, 95% CI (1.23-2.29)), and smoking (per 5 pack-years increase) (OR: 1.10, 95% CI (1.02-1.19)). Adding HCV and history of cannabis inhalation in a sensitivity analysis slightly diminished the association between HIV and AO (OR: 1.71, 95% CI (1.08-2.72)).
Prevalence of AO was higher in HIV-smokers aged ≥ 40 years than in age and gender matched smokers from the general population. HIV was an independent risk factor for AO, even after further adjustment for HCV (a proxy for history of intravenous drug use), and cannabis inhalation. Smoking was associated with AO, underscoring the importance of smoking cessation programs. Finally, both high prevalence and increased risk of AO in HIV-individuals that smoke argue for early systematic diagnosis of AO with spirometry in HIV-smokers ≥ 40 years.